RxDoctor Payments Data

Lillian Takamura

Optometrist · Honolulu, HINPI 1255491809

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,889 of the $10,559 with a category attached, or 65.2%. 19 manufacturers reported payments, led by Bausch & Lomb, A Division Of Bausch Health US, LLC at 29.4% of the total. Reporting peaked in 2019 at $3,607 and has fallen 75.9% since, to $869 in 2025. Among optometrist clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,559in general payments, 2019–2025

Across 160 payments — averaging $65.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb, A Division Of Bausch Health US, LLC$3K
  • Alcon$2K
  • Bausch & Lomb Americas Inc.$1K
  • Novartis$583
  • Amgen$464
  • Aerie Pharmaceuticals, Inc.$375
  • plus $2K from 13 others

What the payments were for

  • Travel & lodging$3,65035%
  • Food & beverage$6,88965%
  • Gifts$190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,559 in reported general payments places this provider in the 95th percentile of 310 optometrist providers in Hawaii.

See all optometrist providers in Hawaii

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost20$14,650
TyrvayaVarenicline Tartrate11$7,348
Latanoprost47$444

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLumigan$355$14,65020 claims
Oyster Point Pharma, Inc.Tyrvaya$152$7,34811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 310 optometrist providers in Hawaii.

Other optometrist in Honolulu

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →